Leqembi

Will the new Alzheimer’s drug put pressure on Medicare premiums?

The FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the advance of Alzheimer’s disease. Although the last Alzheimer’s disease drug caused Medicare Part B premiums to rise an incredible 14.5…

Website by Geiger Computers